President of OCT Consulting
drug discovery and development
Bernard Bourrié has a Ph.D in macromolecular Biology from the University of Montpellier. He has more than 30 years of experience in academic research and the pharmaceutical industry. Before founding OCT, Bernard led teams and developed animal models, mainly in rodents, to support drug discovery and development at Sanofi in the fields of oncology. He was head of the in vivo pharmacology team in Sanofi’s Oncology group in Montpellier and was in charge of several preclinical programs. Bernard managed many studies aiming at determining the potential efficacy of new drugs targeting tumors and their metastasis (antibody-drug conjugates, tubulin binders, platinum, kinases inhibitors). He is the author of several international publications and patents. Bernard also teaches « New R&D strategies in oncology – Cancer personalized medicine » in Medecine and Science Universities in France.
drug discovery and development preclinica and clinical trials